Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 13 | Gourmand Matthew PaulPresident | Option exercise | M | — 14.9K sh | Apr 1, 2026 |
| 13 | Savitz RyanEVP, CFO & CBO | Option exercise · 10b5-1 plan | M | $715K 40.0K sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | Segedi Bryan KDirector | Grant or award | A | $44K 878 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | Ballew NealCHIEF ACCOUNTING OFFICER | Option exercise | M | — 14.9K sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | McClintock WilliamDirector | Grant or award | A | — 52 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | Rogers Matthew CDirector | Grant or award | A | $44K 878 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | Hyun RandyDirector | Grant or award | A | $25K 2,294 sh | Apr 1, 2026 traded Apr 1, 2026 |
| 13 | Pomerantz Jennifer S.Director | Grant or award | A | — 2,351 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | Lillie Charisse RDirector | Grant or award | A | $44K 878 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | Ballew NealCHIEF ACCOUNTING OFFICER | Option exercise | M | — 14.9K sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | Sumner Michael JohnChief Medical Officer | Option exercise | M | — 4,292 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | Bang Jimmy MChief Lending Officer | Option exercise | M | — 1,020 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | Gourmand Matthew PaulPresident | Option exercise | M | — 14.9K sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | Gallo Ann CDirector | Grant or award | A | — 323 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 13 | Mettler JodyChief Operating Officer | Grant or award | A | — 8,000 sh | Apr 1, 2026 traded Mar 30, 2026 |
| 13 | Potts Charles EdwardDirector | Grant or award | A | — 1,186 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 12 | Washington Alex E IiiDirector | Grant or award | A | $73K 524 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 12 | Ramani HiteshChief Accounting Officer | Tax withholding | F | $59K 5,289 sh | Apr 1, 2026 traded Apr 1, 2026 |
| 12 | Brown ShellyEVP, Chief Strategy Officer | Option exercise | M | $100K 3,878 sh | Apr 1, 2026 traded Mar 30, 2026 |
| 12 | Comly Barbara J.EVP, GC & Corporate Secretary | Tax withholding | F | $54K 1,448 sh | Apr 1, 2026 traded Mar 30, 2026 |
| 12 | Brady James AloysiusDirector | Open-market sale · 10b5-1 plan | SELL | $60K 10.8K sh | Apr 1, 2026 traded Mar 30, 2026 |
| 12 | McAleenan KevinDirector, Chief Executive Officer | Tax withholding | F | $139K 39.4K sh | Apr 1, 2026 traded Apr 1, 2026 |
| 12 | Cunningham Gerald EdwinDirector | Grant or award | A | $50K 3,179 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 12 | Natan DavidDirector | Grant or award | A | $129K 276.9K sh | Apr 1, 2026 traded Mar 30, 2026 |
| 12 | Brown ShellyEVP, Chief Strategy Officer | Tax withholding | F | $68K 1,809 sh | Apr 1, 2026 traded Mar 30, 2026 |
| 12 | Brown ShellyEVP, Chief Strategy Officer | Option exercise | M | $100K 8,333 sh | Apr 1, 2026 traded Mar 30, 2026 |
| 12 | Cree BrianPresident & Interim CEO | Grant or award | A | — 54.2K sh | Apr 1, 2026 traded Mar 26, 2026 |
| 12 | Dandekar AtulCSBO | Open-market sale · 10b5-1 plan | SELL | $24K 790 sh | Apr 1, 2026 traded Mar 30, 2026 |
| 12 | Brown ShellyEVP, Chief Strategy Officer | Option exercise | M | $100K 5,040 sh | Apr 1, 2026 traded Mar 30, 2026 |
| 12 | Brown ShellyEVP, Chief Strategy Officer | Option exercise | M | $100K 6,195 sh | Apr 1, 2026 traded Mar 30, 2026 |
| 12 | McAleenan KevinDirector, Chief Executive Officer | Tax withholding | F | $68K 22.4K sh | Apr 1, 2026 traded Mar 31, 2026 |
| 12 | Giordano James NDirector | Grant or award | A | $50K 3,179 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 12 | Brown ShellyEVP, Chief Strategy Officer | Option exercise | M | $100K 6,570 sh | Apr 1, 2026 traded Mar 30, 2026 |
| 11 | Longhito ChristopherFMR SVP & CSCO | Option exercise | M | $47K 1,984 sh | Apr 1, 2026 traded Mar 27, 2026 |
| 9 | Greenwood Matthew AChief Commercial Officer | Tax withholding | F | — 4,151 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 9 | Vougessis EvangelineDirector | Grant or award | A | $13K 2,712 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 9 | Danzey Allen LChief Financial Officer | Tax withholding | F | $1,276 3,189 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 9 | Blankenship CarolynGeneral Counsel and Secretary | Tax withholding | F | $17K 5,606 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 9 | Custin AnnDirector | Grant or award | A | $21K 363 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 9 | Savitz RyanEVP, CFO & CBO | Open-market sale · 10b5-1 plan | SELL | $119K 1,485 sh | Apr 1, 2026 traded Mar 31, 2026 |